Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01173848 · ClinicalTrials.gov registry record · Phase 3
Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients
A Phase 3 study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- Phase 3
- Development phase
- 19
- Enrollment target
NCT01173848 is a Phase 3 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 19 participants.
The verdict
NCT01173848, a Phase 3 study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effectiveness of vitamin D3 versus vitamin D2 in raising vitamin D levels and suppressing parathyroid hormone levels in patients with kidney disease who are not on dialysis.
Interventions
- DRUG Ergocalciferol
- DRUG Cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-10-18 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01173848
The ClinicalTrials.gov registry entry for NCT01173848 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ergocalciferol is the first listed.
NCT01173848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01173848 about?
NCT01173848 is a clinical study titled "Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients". The purpose of this study is to examine the effectiveness of vitamin D3 versus vitamin D2 in raising vitamin D levels and suppressing parathyroid hormone levels in patients with kidney disease who are not on dialysis.
What is the current status of trial NCT01173848?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 19 participants. The study started on 2010-07. Estimated completion is 2011-10-18.
What interventions are being tested in trial NCT01173848?
The interventions under investigation include: Ergocalciferol (DRUG), Cholecalciferol (DRUG).
Who is sponsoring clinical trial NCT01173848?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.